Closantel is an allosteric inhibitor of human Taspase1

to connected objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: Online-Ressource

Language: Englisch

Bibliographic citation: In: iScience, 24.2021, 12; art. 103524, 21 S.

Event: Veröffentlichung

(where): Frankfurt am Main

(who): Universitätsbibliothek Johann Christian Senckenberg

(when): 2021

Creator: Luciano, Vanessa
Proschak, Ewgenij
Langer, Julian David
Knapp, Stefan
Heering, Jan Peter
Marschalek, Rolf

DOI: 10.1016/j.isci.2021.103524

URN: urn:nbn:de:hebis:30:3-779109

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 25.03.2025, 1:42 PM CET

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Luciano, Vanessa
Proschak, Ewgenij
Langer, Julian David
Knapp, Stefan
Heering, Jan Peter
Marschalek, Rolf
Universitätsbibliothek Johann Christian Senckenberg

Time of origin

2021

Other Objects (12)

Hochschulschrift

Escherichia coli 536: ein Modell zum Studium der Pathogenitätsmechanismen von harnwegsinfizierenden E[scherichia]-coli-Stämmen

Synthesis of macrocyclic kinase inhibitors

Development of dual BET/HDAC inhibitors

Rational inhibitor development for epigenetic reader domains

Synthesis and investigation of novel p38 MAPK and DDR kinase inhibitors

Synthesis and optimization of pyrazolo[1,5-α]pyrimidine-based macrocyclic kinase inhibitors

5. Chemische Open-Access-Sonden für epigenetische Zielstrukturen

Using hybrid approaches to study the allosteric regulation of GTP cyclohydrolase I

Dietary compound resveratrol is a pan-BET bromodomain inhibitor

Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.

Structure and inhibitor binding characterization of oncogenic MLLT1 mutants

Catalytic domain plasticity of MKK7 reveals structural mechanisms of allosteric activation and new targeting opportunities

Hochschulschrift

Escherichia coli 536: ein Modell zum Studium der Pathogenitätsmechanismen von harnwegsinfizierenden E[scherichia]-coli-Stämmen

Synthesis of macrocyclic kinase inhibitors

Development of dual BET/HDAC inhibitors

Rational inhibitor development for epigenetic reader domains

Synthesis and investigation of novel p38 MAPK and DDR kinase inhibitors

Synthesis and optimization of pyrazolo[1,5-α]pyrimidine-based macrocyclic kinase inhibitors

5. Chemische Open-Access-Sonden für epigenetische Zielstrukturen

Using hybrid approaches to study the allosteric regulation of GTP cyclohydrolase I

Dietary compound resveratrol is a pan-BET bromodomain inhibitor

Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.

Structure and inhibitor binding characterization of oncogenic MLLT1 mutants

Catalytic domain plasticity of MKK7 reveals structural mechanisms of allosteric activation and new targeting opportunities

Hochschulschrift

Escherichia coli 536: ein Modell zum Studium der Pathogenitätsmechanismen von harnwegsinfizierenden E[scherichia]-coli-Stämmen

Synthesis of macrocyclic kinase inhibitors

Development of dual BET/HDAC inhibitors

Rational inhibitor development for epigenetic reader domains

Synthesis and investigation of novel p38 MAPK and DDR kinase inhibitors

Synthesis and optimization of pyrazolo[1,5-α]pyrimidine-based macrocyclic kinase inhibitors

5. Chemische Open-Access-Sonden für epigenetische Zielstrukturen

Using hybrid approaches to study the allosteric regulation of GTP cyclohydrolase I

Dietary compound resveratrol is a pan-BET bromodomain inhibitor

Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.

Structure and inhibitor binding characterization of oncogenic MLLT1 mutants

Catalytic domain plasticity of MKK7 reveals structural mechanisms of allosteric activation and new targeting opportunities

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Closantel is an allosteric inhibitor of human Taspase1

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Time of origin

Other Objects (12)

Escherichia coli 536: ein Modell zum Studium der Pathogenitätsmechanismen von harnwegsinfizierenden E[scherichia]-coli-Stämmen

Synthesis of macrocyclic kinase inhibitors

Development of dual BET/HDAC inhibitors

Rational inhibitor development for epigenetic reader domains

Synthesis and investigation of novel p38 MAPK and DDR kinase inhibitors

Synthesis and optimization of pyrazolo[1,5-α]pyrimidine-based macrocyclic kinase inhibitors

5. Chemische Open-Access-Sonden für epigenetische Zielstrukturen

Using hybrid approaches to study the allosteric regulation of GTP cyclohydrolase I

Dietary compound resveratrol is a pan-BET bromodomain inhibitor

Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.

Structure and inhibitor binding characterization of oncogenic MLLT1 mutants

Catalytic domain plasticity of MKK7 reveals structural mechanisms of allosteric activation and new targeting opportunities

Escherichia coli 536: ein Modell zum Studium der Pathogenitätsmechanismen von harnwegsinfizierenden E[scherichia]-coli-Stämmen

Synthesis of macrocyclic kinase inhibitors

Development of dual BET/HDAC inhibitors

Rational inhibitor development for epigenetic reader domains

Synthesis and investigation of novel p38 MAPK and DDR kinase inhibitors

Synthesis and optimization of pyrazolo[1,5-α]pyrimidine-based macrocyclic kinase inhibitors

5. Chemische Open-Access-Sonden für epigenetische Zielstrukturen

Using hybrid approaches to study the allosteric regulation of GTP cyclohydrolase I

Dietary compound resveratrol is a pan-BET bromodomain inhibitor

Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.

Structure and inhibitor binding characterization of oncogenic MLLT1 mutants

Catalytic domain plasticity of MKK7 reveals structural mechanisms of allosteric activation and new targeting opportunities

Escherichia coli 536: ein Modell zum Studium der Pathogenitätsmechanismen von harnwegsinfizierenden E[scherichia]-coli-Stämmen

Synthesis of macrocyclic kinase inhibitors

Development of dual BET/HDAC inhibitors

Rational inhibitor development for epigenetic reader domains

Synthesis and investigation of novel p38 MAPK and DDR kinase inhibitors

Synthesis and optimization of pyrazolo[1,5-α]pyrimidine-based macrocyclic kinase inhibitors

5. Chemische Open-Access-Sonden für epigenetische Zielstrukturen

Using hybrid approaches to study the allosteric regulation of GTP cyclohydrolase I

Dietary compound resveratrol is a pan-BET bromodomain inhibitor

Chemical Proteomics Reveals the Target Landscape of Clinical Kinase Inhibitors.

Structure and inhibitor binding characterization of oncogenic MLLT1 mutants

Catalytic domain plasticity of MKK7 reveals structural mechanisms of allosteric activation and new targeting opportunities

Related objects

Reset password